Provided by Tiger Fintech (Singapore) Pte. Ltd.

Opthea Ltd

3.41
0.0000
Volume:- -
Turnover:- -
Market Cap:524.84M
PE:-1.62
High:3.41
Open:3.41
Low:3.41
Close:3.41
Loading ...

Opthea Raises 'Going Concern' Doubts

MT Newswires Live
·
24 Mar

Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure

Stockheads
·
24 Mar

Opthea’s Phase 3 trial results fail to help patients, future of company at risk

The Market Herald
·
24 Mar

Monday’s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results | March 21, 2025

The Market Herald
·
24 Mar

Optima Health CEO Increases Stake Following Administrative Error

TIPRANKS
·
21 Mar

Opthea Limited Suspends Trading Pending Clinical Trial Results

TIPRANKS
·
19 Mar

Ocean Power Technologies Announces Financial Results for Third Quarter Fiscal 2025

GlobeNewswire
·
18 Mar

Trading in Opthea Halted Ahead of Update on Wet AMD Study

Dow Jones
·
17 Mar

Health Check: These biotechs are awaiting key announcements on St Patrick’s Day

Stockheads
·
17 Mar

Opthea Requests Trading Halt

MT Newswires Live
·
17 Mar

JPMorgan Acquires Substantial Stake in Opthea Limited

TIPRANKS
·
14 Mar

Opthea Limited Announces Quotation of New Securities on ASX

TIPRANKS
·
14 Mar

Exploring Three High Growth Tech Stocks In Australia

Simply Wall St.
·
12 Mar

Opthea Limited Announces New Securities Quotation on ASX

TIPRANKS
·
11 Mar

Optima Health PLC Announces Change in Major Holdings

TIPRANKS
·
10 Mar

Scott Power: ASX health sector falls as market faces gathering storm clouds

Stockheads
·
07 Mar

Opthea First Half 2025 Earnings: US$0.11 loss per share (vs US$0.17 loss in 1H 2024)

Simply Wall St.
·
06 Mar

ASX February health winners: Sector falls almost 8pc in weaker month for markets

Stockheads
·
05 Mar

Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target

TIPRANKS
·
03 Mar

Opthea Announces Phase 2b Wet AMD Publication

GlobeNewswire
·
03 Mar